Synergistic therapeutic compositions comprising at least one lig

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514563, A61K 31335, A61K 31195

Patent

active

057671486

ABSTRACT:
Pharmaceutical/dermatological compositions comprising (a) at least one first ligand displaying selective activity for the RXR receptors and (b) at least one second ligand displaying selective activity for the RAR-.alpha. receptor, are useful for modulating the proliferation and/or differentiation of HL-60 type cells, in particular for the systemic treatment of acute promyelocytic leukemia.

REFERENCES:
Proc Annu Meet Am Assoc Cancer Res; 33:A565-6 15-07-92, Sporn MB et al, p. 566, col. 1.
Blood, 84 (2) 1994, 446-452, Dawson et al, p. 448, Col. 2, Line 3, p. 450, Col. 2.
Nucleic Acids Res, Mar. 11, 1993, 21 (5), P1231-7, England, Schrader et al.
New Engl. J. Med. 1993, 329/3 (177-189), USA, p. 186, Col. 1, Line 3, Col. 2.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Synergistic therapeutic compositions comprising at least one lig does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergistic therapeutic compositions comprising at least one lig, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic therapeutic compositions comprising at least one lig will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1726455

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.